Global Blood Collection Market Insights Forecasts to 2033

• The Global Blood Collection Market Size was Valued at USD 11.51 Billion in 2023
• The Market Size is Growing at a CAGR of 8.02% from 2023 to 2033
• The Worldwide Blood Collection Market Size is Expected to Reach USD 24.90 Billion by 2033
• North America is Expected to Grow the fastest during the forecast period.

The Global Blood Collection Market Size is Anticipated to Exceed USD 24.90 Billion by 2033, Growing at a CAGR of 8.02% from 2023 to 2033.

Market Overview

Blood collection is defined as the obtaining of blood from a patient or donor for various medical purposes including diagnostic tests, transfusions, and research. It usually involves using a needle to pierce a vein, usually in the arm, and letting the blood flow via carefully sterile tubes or containers. The collected blood is subsequently processed and analyzed to offer information about a person's health, such as disease diagnosis, condition monitoring, and blood type determination. Blood can be collected at hospitals, clinics, or specialist blood donation centers. It is applied in the detection of health conditions, management of chronic diseases, safe blood transfusion, sustaining scientific studies, and collection of blood donations.

According to a World Health Organization (WHO) report in June 2023, 118.5 million blood donations were collected globally, with 40% in high-income countries. The majority of blood transfusions are given to over 60-year-olds in high-income countries. The blood donation rate varies across different income levels, with high-income countries having the highest rate at 31.5 donations, followed by upper-middle-income countries at 16.4, lower-middle-income countries at 6.6, and low-income countries at 5.0. From 2008 to 2018, voluntary unpaid blood donations increased by 10.7 million. 79 countries rely on voluntary unpaid blood donors for over 90% of their blood supply, while 54 countries rely on family/replacement or paid donors for over 50%. Only 56 out of 171 countries produce plasma-derived medicinal products (PDMP) through fractionation, with 91 countries reporting all PDMPs being imported. The volume of plasma for fractionation per 1000 population varies significantly between countries ranging from 0.1 to 52.6 litres, with a median of 5.2 litres.

Report Coverage

This research report categorizes the market for blood collection based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the blood collection market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the blood collection market.

Driving Factors

The blood collection market is driven by several driving factors including the rising prevalence of chronic diseases, an aging population, and advancements in technology that contribute to increased demand for blood tests and collection procedures. Additionally, growing health awareness, expanding healthcare infrastructure, and government initiatives supporting healthcare services further drive market expansion. The emphasis on diagnostic testing, coupled with the rise in blood donation campaigns and the emergence of innovative market players, also plays a crucial role. Stringent regulatory and quality standards ensure safety and reliability, enhancing trust and contributing to the growth of the blood collection market.  

Restraining Factors

The blood collection market faces several restraining factors including high costs associated with advanced technologies, risks of infection during procedures, and a shortage of trained personnel pose significant challenges. Additionally, stringent regulatory requirements and inadequate infrastructure in some regions can limit market expansion. Patient reluctance and intense competition further complicate the landscape, while rapid technological advancements may lead to obsolescence and necessitate constant investment.

Market Segmentation

The blood collection market share is classified intoproduct, application, and end user.

• The needles and syringes segment is estimated to hold the highest market revenue share through the projected period.

Based on the product, the blood collection market is classified into needles and syringes, blood collection tubes, blood lancets, blood bags, and others. Among these, the needles and syringes segment is estimated to hold the highest market revenue share through the projected period. The needle and syringe segment is attributed to the increasing use of needles and syringes in blood collection for the diagnosis of various chronic diseases, as well as the rising prevalence of infectious diseases. The phlebotomist must be fully knowledgeable of the various needles, tubes, and syringes that might be used during the blood collection operation.

• The diagnostics segment is anticipated to hold the largest market share through the forecast period.

Based on the application, the blood collection market is divided into diagnostics and treatment. Among these, the diagnostics segment is anticipated to hold the largest market share through the forecast period. Due to the unconditional increase in laboratory diagnostic applications in blood collection products, and research and development activities for disease diagnosis continued to increase, this trend further contributed to the segment expansion. Anemia-related diseases like chronic leukemia and certain kinds of kidney disease fall into this category. In addition, patients who have had traffic accidents or been injured in natural disasters often get transfusions for severe blood short driving the diagnostic segment leadership in the market.

• The hospitals and diagnostic centers segment dominates the market with the largest market share through the forecast period.

Based on the end user, the blood collection market is categorized into hospitals and diagnostic centers, blood banks, and others. Among these, the hospitals and diagnostic centers segment dominates the market with the largest market share through the forecast period. This dominance is driven by the high volume of blood collection activities focused in these settings, including routine tests, emergency diagnostics, and a wide range of medical procedures.

Regional Segment Analysis of the Blood Collection Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

Asia Pacific is anticipated to hold the largest share of the blood collection market over the predicted timeframe.

Asia Pacific is anticipated to hold the largest share of the blood collection market over the predicted timeframe. Asia Pacific region is attributed to rapidly growing population, increased healthcare investments, and rising prevalence of chronic diseases. Top of FormFor blood collection, there is increasing demand which has spurred progress in healthcare infrastructure across the region. With government support and economic expansion, diagnostic service capability developments increase in this part of Asia Pacific making it a pivotal region for blood collection worldwide.

North America is expected to grow at the fastest CAGR growth of the blood collection market during the forecast period. The rapid growth can be attributed to the advanced infrastructure of healthcare settings, a high prevalence of chronic diseases, and successive technological innovations in the area. Spending more on healthcare and exerting special focus on preventive care increases the demand for blood collection services. The presence of a number of key players within the regional boundary and continuous developments in diagnostic technologies are some of the other factors contributing to North America accounting for the highest growth rate of the blood collection market.  

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the blood collection market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Abbott Laboratories
• Haemonetics Corp.
• Terumo Corp.
• Medtronic Plc.
• BD
• Becton
• Dickinson and Company
• Terumo Medical Corporation
• Narang Medical Limited
• Qiagen
• NIPRO Medical Corp.
• Greiner Holding AG
• FL Medical S.R.L.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In May 2024, Vitestro raised €20 million to expedite the commercialization of its autonomous blood sampling instrument.

• In April 2024, Streck announced the introduction of Protein Plus BCTTM, a direct draw whole blood collection tube designed to maintain draw-time plasma protein concentrations during ambient temperature storage.

• In March 2024, Babson Diagnostics, an Austin-based healthcare technology firm, announced that its BetterWay blood testing system would be available in certain Austin H-E-B pharmacies, Peoples Rx, and Lake Hills Pharmacy beginning in July.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the blood collection market based on the below-mentioned segments:   

Global Blood Collection Market, By Product

• Needles and Syringes
• Blood Collection Tubes
• Blood Lancets
• Blood Bags
• Others

Global Blood Collection Market, By Application

• Diagnostics
• Treatment

Global Blood Collection Market, By End User

• Hospitals and Diagnostic Centers
• Blood Banks
• Others

Global Blood Collection Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa